These Biotech Stocks Are Cheap Based On 1 Fundamental Measure

With the Federal Reserve lifting interest rates for the first time in more than three years and signalling that money will not be cheap again quickly, investors are being pushed to think harder about where real growth could justify the risk
Read more...